Search Within

Jose T Baselga

  1. "Gynecologic Medicine Service"
Formats
  1. Journal Article (13)
  2. Meeting Abstract (13)
Groups
  1. Department of Medicine (26)
  2. Gynecologic Medicine Service (26)
  3. Solid Tumor Oncology Division (26)
  4. Breast Medicine Service (20)
  5. GSK Faculty (17)
  6. Human Oncology and Pathogenesis Program (17)

More Groups

People
  1. David Hyman (16)
  2. David Solit (12)
  3. Michael Berger (11)
  4. Lillian Smyth (10)
  5. Tiffany Traina (10)
  6. Alison Schram (9)

More People

Years
  1. 2021 (1)
  2. 2020 (2)
  3. 2019 (1)
  4. 2018 (5)
  5. 2017 (7)
  6. 2016 (3)

More Years

Publications
  1. Journal of Clinical Oncology (8)
  2. Annals of Oncology (3)
  3. Cancer Research (3)
  4. Cancer Discovery (2)
  5. Breast Cancer Research and Treatment (1)
  6. Clinical Breast Cancer (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (9)
  2. American Association for Cancer Research (6)
  3. Nature Publishing Group (4)
  4. Oxford University Press (3)
  5. Elsevier Inc. (2)
  6. American Medical Association (1)

More Publishers

Results (26)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Precision medicine at Memorial Sloan Kettering Cancer Center: Clinical next-generation sequencing enabling next-generation targeted therapy trials
    Journal Article

    Hyman, D. M.; Solit, D. B.; Arcila, M. E.; Cheng, D. T.; Sabbatini, P.; Baselga, J.; Berger, M. F.; Ladanyi, M.
    Drug Discovery Today (2015)

    Fulltext@MSK | Save
  • Phase II study of weekly paclitaxel with trastuzumab and pertuzumab in patients with HER2-overexpressing metastatic breast cancer (MBC): Updated progression-free survival with overall survival result
    Meeting Abstract

    Smyth, L. M.; Iyengar, N. M.; Chandarlapaty, S.; Sugarman, S.; Comen, E. A.; Drullinsky, P.; Sklarin, N. T.; Traina, T. A.; Troso-Sandoval, T. A.; Patil, S.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Is next generation sequencing (NGS) ready for routine clinical practice in gliomas? Results of a prospective study utilizing the MSK-IMPACT assay
    Meeting Abstract

    Omuro, A. M. P.; Zehir, A.; Cheng, D. T.; Berger, M. F.; Hyman, D. M.; Solit, D. B.; Baselga, J.; Ladanyi, M.; Arcila, M. E.; Hameed, M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Phase II feasibility study of paclitaxel (T) with trastuzumab (H) and lapatinib (L) for node-negative, HER2-positive breast cancer (BC)
    Meeting Abstract

    Iyengar, N. M.; Fornier, M. N.; Sugarman, S.; Theodoulou, M.; Troso-Sandoval, T. A.; D'Andrea, G.; Drullinsky, P.; Fasano, J.; Gajria, D.; Goldfarb, S. B.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • A virtual consult service to optimize clinical trial participation in patients with metastatic breast cancer
    Meeting Abstract

    Cadoo, K. A.; Shah, P. D.; Charen, A. S.; Bromberg, J.; Comen, E. A.; D'Andrea, G.; Dang, C. T.; Gilewski, T.; Gucalp, A.; Lake, D.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Anti-epidermal growth factor receptor monoclonal antibody treatment of A431 cells decreases cisplatin /DNA adduct repair in association with NF-KB induction
    Meeting Abstract

    Aghajanian, C.; Zhuo, Y.; Ho, T. Y.; Brown, C.; Fan, Z.; Baselga, J.; Mendelsohn, J.; Spriggs, D. R.
    Proceedings of the American Association for Cancer Research Annual Meeting (1995)

    Fulltext@MSK | Save